BOUDREAUX GAIL

Gail Boudreaux bought 8,500 Elevance Health shares in three tranches on July 18, 2025, at $286.07-$287.96, then bought again a year later — 2,725 shares on July 17, 2026, at $366.41-$368.25, a price 27.8% higher. Genuine open-market purchases ("P"-coded, not option exercises) are rare among insiders generally; two consecutive years of them from the same executive, in the same month, is a real and unusual pattern. Her history also includes 962,409 UnitedHealth Group shares sold as CEO there from 2008-2014, and director seats at Zimmer Holdings, Xcel Energy, Genzyme, Target, and a rare 100,000-share Novavax purchase in 2015 — none of which show the recurring purchase pattern visible at Elevance Health.